Your browser doesn't support javascript.
loading
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.
Kelemen, Linda E; Earp, Madalene; Fridley, Brooke L; Chenevix-Trench, Georgia; Fasching, Peter A; Beckmann, Matthias W; Ekici, Arif B; Hein, Alexander; Lambrechts, Diether; Lambrechts, Sandrina; Van Nieuwenhuysen, Els; Vergote, Ignace; Rossing, Mary Anne; Doherty, Jennifer A; Chang-Claude, Jenny; Behrens, Sabine; Moysich, Kirsten B; Cannioto, Rikki; Lele, Shashikant; Odunsi, Kunle; Goodman, Marc T; Shvetsov, Yurii B; Thompson, Pamela J; Wilkens, Lynne R; Dörk, Thilo; Antonenkova, Natalia; Bogdanova, Natalia; Hillemanns, Peter; Runnebaum, Ingo B; du Bois, Andreas; Harter, Philipp; Heitz, Florian; Schwaab, Ira; Butzow, Ralf; Pelttari, Liisa M; Nevanlinna, Heli; Modugno, Francesmary; Edwards, Robert P; Kelley, Joseph L; Ness, Roberta B; Karlan, Beth Y; Lester, Jenny; Orsulic, Sandra; Walsh, Christine; Kjaer, Susanne K; Jensen, Allan; Cunningham, Julie M; Vierkant, Robert A; Giles, Graham G; Bruinsma, Fiona.
Afiliación
  • Kelemen LE; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA. Kelemen@musc.edu.
  • Earp M; Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA. Kelemen@musc.edu.
  • Fridley BL; Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN 55905, USA. madalene.earp@ucalgary.ca.
  • Chenevix-Trench G; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612 USA. brooke.fridley@moffitt.org.
  • Fasching PA; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
  • Beckmann MW; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
  • Ekici AB; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center, 91054 Erlangen, Germany. peter.fasching@uk-erlangen.de.
  • Hein A; Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA. peter.fasching@uk-erlangen.de.
  • Lambrechts D; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center, 91054 Erlangen, Germany. fk-direktion@uk-erlangen.de.
  • Lambrechts S; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen 91054, Germany. arif.ekici@uk-erlangen.de.
  • Van Nieuwenhuysen E; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center, 91054 Erlangen, Germany. alexander.hein@uk-erlangen.de.
  • Vergote I; Vesalius Research Center, University of Leuven, Leuven 3001, Belgium. diether.lambrechts@vib-kuleuven.be.
  • Rossing MA; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven 3000, Belgium. diether.lambrechts@vib-kuleuven.be.
  • Doherty JA; Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven 3000, Belgium. sandrina.lambrechts@mumc.nl.
  • Chang-Claude J; Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven 3000, Belgium. els.vannieuwenhuysen@uzleuven.be.
  • Behrens S; Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven 3000, Belgium. ignace.vergote@uzleuven.be.
  • Moysich KB; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. mrossing@fhcrc.org.
  • Cannioto R; Department of Epidemiology, University of Washington, Seattle, WA 98402, USA. mrossing@fhcrc.org.
  • Lele S; Huntsman Cancer Institute, Department of Population Health Sciences, University of Utah, Salt Lake City, UT 84112, USA. jennifer.doherty@hci.utah.edu.
  • Odunsi K; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany. j.chang-claude@dkfz-heidelberg.de.
  • Goodman MT; University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany. j.chang-claude@dkfz-heidelberg.de.
  • Shvetsov YB; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany. s.behrens@dkfz.de.
  • Thompson PJ; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. moysich@roswellpark.org.
  • Wilkens LR; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. rikki.cannioto@roswellpark.org.
  • Dörk T; Department of Gynecological Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. shashi.lele@roswellpark.org.
  • Antonenkova N; Department of Gynecological Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. kunle.odunsi@roswellpark.org.
  • Bogdanova N; Department of Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. marc.goodman@cshs.org.
  • Hillemanns P; Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. marc.goodman@cshs.org.
  • Runnebaum IB; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI 96813, USA. yshvetso@cc.hawaii.edu.
  • du Bois A; Department of Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. pamela.thompson@cshs.org.
  • Harter P; Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. pamela.thompson@cshs.org.
  • Heitz F; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI 96813, USA. lynne@cc.hawaii.edu.
  • Schwaab I; Gynaecology Research Unit, Hannover Medical School, Hannover 30625, Germany. doerk.thilo@mh-hannover.de.
  • Butzow R; Byelorussian Institute for Oncology and Medical Radiology Aleksandrov N.N., Minsk 223040, Belarus. antonenkova.natalia.omd@tut.by.
  • Pelttari LM; Gynaecology Research Unit, Hannover Medical School, Hannover 30625, Germany. bogdanova.natalia@mh-hannover.de.
  • Nevanlinna H; Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover 30625, Germany. hillemanns.peter@mh-hannover.de.
  • Modugno F; Department of Gynecology, Jena University Hospital-Friedrich Schiller University, Jena 07743, Germany. ingo.runnebaum@med.uni-jena.de.
  • Edwards RP; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte (KEM), Essen 45136, Germany. prof.dubois@googlemail.com.
  • Kelley JL; Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden 65199, Germany. prof.dubois@googlemail.com.
  • Ness RB; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte (KEM), Essen 45136, Germany. p.harter@gmx.de.
  • Karlan BY; Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden 65199, Germany. p.harter@gmx.de.
  • Lester J; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte (KEM), Essen 45136, Germany. florian.heitz@gmx.net.
  • Orsulic S; Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden 65199, Germany. florian.heitz@gmx.net.
  • Walsh C; Praxis für Humangenetik, Wiesbaden 65187, Germany. iraschwaab@gmx.de.
  • Kjaer SK; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki 00290, Finland. ralf.butzow@hus.fi.
  • Jensen A; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki 00290, Finland. ralf.butzow@hus.fi.
  • Cunningham JM; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki 00290, Finland. liisa.pelttari@helsinki.fi.
  • Vierkant RA; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki 00290, Finland. heli.nevanlinna@hus.fi.
  • Giles GG; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. fm@cs.cmu.edu.
  • Bruinsma F; Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA 15213, USA. fm@cs.cmu.edu.
Int J Mol Sci ; 19(9)2018 08 21.
Article en En | MEDLINE | ID: mdl-30134598
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Timidilato Sintasa / Proteínas / Regulación Neoplásica de la Expresión Génica / ARN sin Sentido / Adenocarcinoma Mucinoso / Polimorfismo de Nucleótido Simple Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans / Middle aged Idioma: En Revista: Int J Mol Sci Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Timidilato Sintasa / Proteínas / Regulación Neoplásica de la Expresión Génica / ARN sin Sentido / Adenocarcinoma Mucinoso / Polimorfismo de Nucleótido Simple Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans / Middle aged Idioma: En Revista: Int J Mol Sci Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos